Keith Katkin - May 19, 2025 Form 4 Insider Report for Syndax Pharmaceuticals Inc (SNDX)

Role
Director
Signature
/s/ Michael A. Metzger, as Attorney-in-Fact
Stock symbol
SNDX
Transactions as of
May 19, 2025
Transactions value $
$91,120
Form type
4
Date filed
5/19/2025, 04:01 PM
Previous filing
May 2, 2025
Next filing
May 28, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Katkin Keith Director C/O SYNDAX PHARMACEUTICALS, INC., 730 THIRD AVENUE, FLOOR 9, NEW YORK /s/ Michael A. Metzger, as Attorney-in-Fact 2025-05-19 0001314596

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNDX Common Stock Purchase $91.1K +10K +11.11% $9.11 100K May 19, 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.